PICU-related Sleep and Circadian Dysregulation Pilot Study
Launched by STATE UNIVERSITY OF NEW YORK AT BUFFALO · Jul 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The PICU-related Sleep and Circadian Dysregulation Pilot Study is a research project aimed at understanding how sleep and daily rhythms can be affected in critically ill children aged 3 to 6 years. The study will look at two main things: how we can track sleep and daily cycles using special wrist devices and saliva samples, and whether getting more natural light during the day and limiting eating to daytime hours can help improve sleep quality for these children.
To participate, children must be between 3 and 6 years old and expected to stay in the Pediatric Intensive Care Unit (PICU) for at least one day. An English-speaking parent or caregiver needs to be present at the bedside. However, children who are receiving end-of-life care or certain medications that affect muscle control cannot take part in this study. If eligible, participants can expect to help researchers learn more about improving sleep for kids in the PICU, which could lead to better care in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Child age 3 to 6 years old on the day of PICU admission
- • 2. English-speaking parent at the bedside
- • 3. Child expected to remain in the PICU over 24 to 48 hours
- Exclusion Criteria:
- • 1. Child is in end-of-life care
- • 2. The child is receiving neuromuscular blockade for any reason
- • 3. Caregiver or parent not at the bedside
About State University Of New York At Buffalo
The State University of New York at Buffalo (SUNY Buffalo) is a prominent research institution dedicated to advancing healthcare through innovative clinical trials and studies. Renowned for its commitment to academic excellence and interdisciplinary collaboration, the university leverages its extensive resources and expertise to explore novel therapeutic approaches and enhance patient outcomes. SUNY Buffalo's clinical trials encompass a wide range of medical disciplines, driven by a mission to translate research discoveries into practical applications that benefit diverse populations. With a focus on ethical standards and rigorous methodologies, the university fosters an environment that supports cutting-edge research while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Buffalo, New York, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported